Month: December 2025

Zurich, Switzerland – December 11, 2025 – Santersus AG today announced two senior leadership appointments that strengthen the company’s executive and governance capabilities as it advances its NucleoCapture™ toward pivotal clinical development. James Ladtkow Appointed as Chief Executive Officer Santersus has appointed James Ladtkow as Chief Executive Officer, effective immediately. Mr. Ladtkow (BSME, MBA) brings …

Santersus AG Appoints New Chief Executive Officer and Expands Board of Directors Read More »

Zurich, Switzerland – December 1, 2025 – Santersus AG today announced the successful completion of its Series A financing, led by Norcliffe, a UK life sciences fund with participation from Terumo Ventures. The financing will support the advancement of Santersus’ NucleoCapture™ into pivotal clinical development while accelerating progress across Santersus’ broader pipeline. Santersus has entered …

Santersus AG Completes Series A Financing led by Norcliffe Capital, joined by Terumo Ventures, and Announces Strategic Collaboration with Terumo Corporation and Advancement of NucleoCapture into Pivotal Clinical Development Read More »